Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases
Clinical trial NCT02707211 · UNKNOWN
Trial details
- NCT number
- NCT02707211
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.